Role of mast cell chymase in allergen-induced biphasic skin reaction.

[1]  P. Cui,et al.  Chymase is a potent chemoattractant for human monocytes and neutrophils , 2000, Journal of leukocyte biology.

[2]  C. Craik,et al.  Cathepsin G Activates Protease-activated Receptor-4 in Human Platelets* , 2000, The Journal of Biological Chemistry.

[3]  T. Ochi,et al.  Different role of IL‐4 in the onset of hapten‐induced contact hypersensitivity in BALB/c and C57BL/6 mice , 2000, British journal of pharmacology.

[4]  M. Miyazaki,et al.  Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. , 2000, Drug design and discovery.

[5]  M. Miyazaki,et al.  Chymase: its pathophysiological roles and inhibitors. , 1998, Current pharmaceutical design.

[6]  A. Walls,et al.  Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo , 1998, British journal of pharmacology.

[7]  H. Okunishi,et al.  Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase , 1998, Archives of Dermatological Research.

[8]  幸夫 佐藤,et al.  マウスのI型(即時型および遅発型)およびIV型(遅延型)皮膚アレルギー反応に対するタクロリムス軟膏の作用 , 1998 .

[9]  N. Inagaki,et al.  Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice. , 1998, Life sciences.

[10]  A. Walls,et al.  The induction of a prolonged increase in microvascular permeability by human mast cell chymase. , 1998, European journal of pharmacology.

[11]  C. Scudamore,et al.  The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. , 1998, European journal of cell biology.

[12]  S. Durham,et al.  IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. , 1998, The Journal of allergy and clinical immunology.

[13]  R. Halaban,et al.  Chymase cleavage of stem cell factor yields a bioactive, soluble product. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Durham,et al.  Eosinophils and eosinophil-associated cytokines in allergic inflammation. , 1997, International archives of allergy and immunology.

[15]  M. Welle.  Development, significance, and heterogeneity of mast cells with particular regard to the mast cell‐specific proteases chymase and tryptase , 1997, Journal of leukocyte biology.

[16]  T. Tanaka,et al.  Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. , 1997, Biochimica et biophysica acta.

[17]  C. Scudamore,et al.  Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum , 1995, The Journal of experimental medicine.

[18]  N. Inagaki,et al.  An immunopharmacological study of the biphasic allergic skin reaction in mice. , 1995, Biological & pharmaceutical bulletin.

[19]  M. Tsujimoto,et al.  Purification of soluble murine interleukin 5 (IL-5) receptor alpha expressed in Chinese hamster ovary cells and its action as an IL-5 antagonist. , 1993, Archives of biochemistry and biophysics.

[20]  K. Takatsu,et al.  Role of CD4+ T lymphocytes and interleukin‐5 in antigen‐induced eosinophil recruitment into the site of cutaneous late‐phase reaction in mice , 1992, Journal of leukocyte biology.

[21]  R. Black,et al.  Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase , 1991, The Journal of experimental medicine.

[22]  R. Graham,et al.  Cloning of the gene and cDNA for human heart chymase. , 1991, The Journal of biological chemistry.

[23]  K. Nishioka,et al.  Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/C mice by monoclonal anti-DNP IgE antibody: possible implications for skin lesion formation in atopic dermatitis. , 1990, International archives of allergy and applied immunology.

[24]  K. Austen,et al.  Mast Cell and Basophil Differentiation and Function in Health and Disease , 1989 .

[25]  Y. Kitamura,et al.  Substance P induces granulocyte infiltration through degranulation of mast cells. , 1989, Journal of immunology.

[26]  N. Inagaki,et al.  Homologous passive cutaneous anaphylaxis in various strains of mice. , 1987, International archives of allergy and applied immunology.

[27]  K. Austen,et al.  Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C. , 1986, Journal of immunology.

[28]  M. Tharp,et al.  Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies. , 1983, Journal of immunology.

[29]  Maeyama Kazutaka,et al.  Tissue distribution of histamine in a mutant mouse deficient in mast cells: Clear evidence for the presence of non-mast-cell histamine , 1982 .

[30]  W. Henderson,et al.  The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. , 1980, Journal of immunology.

[31]  Y. Kitamura,et al.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. , 1978, Blood.